Pharmacovigilance is a non-negotiable regulatory obligation for every pharmaceutical company with a marketed product. The global pharmacovigilance market reached $9.8 billion in 2025 and continues to grow as product portfolios expand and international safety reporting requirements multiply across ICH regions. Drug safety departments and specialist PV service providers are under continuous pressure to process higher volumes of adverse event reports with greater regulatory precision — often without proportional headcount growth.
The Drug Safety Journal published research in 2025 indicating that up to 40% of pharmacovigilance operational work at both sponsor companies and specialized PV service organizations is administrative in nature — data entry, document compilation, deadline tracking, and reporting logistics that do not require medical or scientific expertise. Virtual assistants are absorbing that administrative layer with meaningful results.
Adverse Event Intake and Initial Triage Support
The adverse event intake process begins the moment a safety report is received — whether via phone, email, patient support program, or literature surveillance. Initial intake involves capturing reporter contact information, documenting the reported event in standard terminology, assigning case priority, and routing the case to the appropriate medical assessor. This intake and triage workflow is highly procedural and volume-driven.
Virtual assistants can support the intake layer by managing adverse event report email and voicemail queues, capturing initial case data from structured intake forms, entering case demographics and event data into safety database fields for medical assessor review, and maintaining the intake log with timestamps and routing records. For PV departments managing high-volume consumer product or OTC drug portfolios, VA-supported intake can process initial data capture faster than relying entirely on clinical staff.
It is critical to note that medical assessment of adverse event causality and seriousness classification must be performed by qualified pharmacovigilance professionals — VAs support the administrative infrastructure of intake without making medical judgments.
Periodic Safety Report Compilation
Individual Case Safety Reports are the most frequent PV output, but Periodic Benefit-Risk Evaluation Reports (PBRERs) and Periodic Adverse Drug Experience Reports (PADERs) are the most administratively intensive. These comprehensive periodic reports require aggregating safety data, compiling literature summaries, organizing signal detection outputs, and formatting extensive documents to ICH E2C guidelines.
Virtual assistants can manage the document production layer: maintaining the compilation schedule and sending reminders to responsible medical writers, organizing input documents from signal detection, clinical, and regulatory teams, applying formatting standards to compiled PBRER/PADER sections, managing version tracking through internal review cycles, and preparing the final document package for submission. While medical writers and PV scientists own the content, VAs own the logistics that ensure content arrives assembled, formatted, and on time.
ICH E2C(R2) requires PBRERs at defined intervals for each approved indication, and EMA adds additional submission requirements for EU marketing authorizations. Managing the PBRER calendar across a multi-product portfolio without dedicated administrative support is a persistent operational challenge for PV departments.
Compliance Calendar and Regulatory Deadline Management
Safety reporting deadlines are strictly enforced by regulatory authorities worldwide. Expedited reports for serious unexpected adverse reactions must reach the FDA within 15 days and EMA within 15 calendar days under EudraVigilance requirements. Missing these deadlines can result in warning letters, regulatory sanctions, and reputational damage.
Virtual assistants can build and maintain a regulatory reporting calendar covering all products, indications, and reporting jurisdictions, send advance reminders to PV operations staff at 7-, 3-, and 1-day intervals before expedited report deadlines, track submission confirmation numbers and acknowledgment receipts, and generate weekly compliance status dashboards for PV management review. This compliance calendar function is one of the highest-value VA tasks in pharmacovigilance — it is deadline-driven, consequential, and requires no medical expertise.
Literature Surveillance Administrative Support
Pharmacovigilance regulations require systematic literature surveillance to identify safety-relevant publications. Running structured searches in PubMed, EMBASE, and WHO databases, screening titles and abstracts for relevance, and maintaining surveillance logs are administrative tasks that consume significant PV staff time.
Virtual assistants can execute literature surveillance searches on defined schedules, organize results in citation management platforms, perform initial title and abstract screening against defined relevance criteria for PV scientist review, and maintain surveillance logs with search dates, terms, and results counts. This creates a sustainable, documented literature surveillance workflow that satisfies regulatory expectations without requiring a PV scientist to run every search.
For pharmacovigilance departments and PV service organizations looking to increase throughput and maintain compliance at scale, Stealth Agents provides trained virtual assistants experienced in safety database support, compliance calendar management, and periodic report administration.
Sources
- Drug Safety Journal, Administrative Task Distribution in Pharmacovigilance Operations, 2025
- ICH, E2C(R2) Periodic Benefit-Risk Evaluation Report Guidance, current
- EMA, EudraVigilance Reporting Requirements, 2024
- FDA, Postmarketing Safety Reporting Requirements, current